Kala Pharma Sinks on Mixed Data From Two Phase III Dry Eye Disease Studies

Post author:Sam
Post published:January 4, 2018
Post category:BioPharma

Kala Pharma released mostly positive topline results from two Phase III clinical trials for KPI-121 in patients with dry eye disease.
Source: BioSpace

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

News

Career

Request a Quote

You Might Also Like